Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis

Comparison of dalbavancin with standard of care in the management of infective endocarditis: efficacy, safety, and cost analysis

Objectives: Due to its long half-life, dalbavancin offers benefits for long-duration treatments, especially osteoarticular and infective endocarditis (IE). We evaluated the efficacy and costs of IE treatment, comparing dalbavancin with standard of care (SOC). Methods: Retrospective multicenter cohor...

Full description

Bibliographic Details
Main Authors: Milagros Suárez, Antonio Pérez-Landeiro, Ana Sanjurjo, Olalla Lima, Adrián Sousa, Ana López, Lucía Martínez-Lamas, Xurxo Cabrera, Martín Rubianes, María Teresa Pérez-Rodríguez
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:International Journal of Infectious Diseases
Subjects:
Infective endocarditis
Sequential therapy
Dalbavancin
Cost analysis
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971223007646

Internet

http://www.sciencedirect.com/science/article/pii/S1201971223007646

Similar Items